AT&T will purchase the operations in an all-cash transaction valued at approximately $780 million
Breaking News
Progenics Pharmaceuticals today announced that it has acquired Molecular Insight Pharmaceuticals
Subscribe to VCpost newsletter
Most Popular
- Whistleblower Claims GlaxoSmithKline Lied to FDA, Federal Government About Zantac Safety Claims
- Social Security Income Payments to Jump by $60 Monthly in 2025 Amid Persistent Inflation
- Rising Property Insurance Rates in Florida Forcing Nursing Homes to Close: Report
- Joe Biden Billionaire Megadonor Faces Being Ousted From Own Tech Company Over 'Concerns’ About His Conduct
- OpenAI CEO Sam Altman Is 'Embarrassed' Over Company's Threat to Revoke Equity if Exiting Employees Refuse to Sign NDA
- Donald Trump's Social Media Company Receives Inquiry From Financial Industry Regulatory Authority
- VinFast Under Federal Investigation Over VF 8 Electric Vehicle Crash in California That Killed Family of Four
- McDonald's Adds New 'Grandma McFlurry' to Its Dessert Menu for Limited Time
